Lenskart posted a 182.3% YoY surge in net profit, lifting its shares 7% to Rs 627. Most brokerages raised target prices, while Citi maintained a neutral rating.

Key Takeaways

  • Q1 net profit up 182.3% to Rs 228 crore.
  • Shares jumped 7% to Rs 627 after strong margin expansion.
  • Most brokerages upgraded targets; only Citi stayed neutral.

Q1 Performance Highlights

Lenskart reported revenue of Rs 2,214 crore, a 33.6% YoY increase, and EBITDA of Rs 589 crore, up 61.3%. Consolidated product margin crossed 70% for the first time, reaching 70.3% versus 68.7% a year earlier.

Brokerage Ratings and Target Prices

Jefferies kept a Buy rating and lifted its target to Rs 680 (from Rs 600). Morgan Stanley gave an Overweight rating with a Rs 666 target. Goldman Sachs upgraded to Accumulate with a Rs 715 target, while Motilal Oswal raised its Buy target to Rs 705. Citi remained neutral, setting a Rs 650 target.

Why This Matters

BozokMedia analysis shows that Lenskart’s rapid revenue growth and margin expansion create attractive upside for investors, driven by international expansion and premium‑product demand.

"Lenskart’s international footprint and premiumisation strategy will be the keystones of sustained earnings growth."
Did You Know?: The company launched 70,000 daily eye‑tests in 2024, turning supply constraints into a new growth lever.

Frequently Asked Questions

Q1: Should investors buy Lenskart stock now?
A1: With most brokerages bullish and target prices indicating upside, the stock still offers potential gains, though valuation already reflects much of the expected growth.

Q2: What is the outlook for Lenskart’s international business?
A2: International revenue grew 38% YoY, and continued margin improvement could significantly boost overall earnings.